Novel organometallic compounds for cancer treatment
Loading...
Date
2013
Authors
Zhanbossinova, A.
Yespolayeva, S.
Khamitova, G.
Negmetzhanov, B.
Alibek, K.
Adilov, S.
Journal Title
Journal ISSN
Volume Title
Publisher
Nazarbayev University
Abstract
Incorporating indole, resorcinol, and porphyrin derivatives into ferrocene and ruthenium complexes could improve their anticancer activity. These compounds are furnished with functional groups which are expected to induce programmed cell death and show high selectivity to cancer cells. Currently, they are at the stage of in vitro testing for anticancer activity.
Description
Keywords
first research week, cancer treatment, anticancer activity